Roth Capital Initiates Plasmatech With Buy

Roth Capital initiated coverage on

with a Buy rating. The target price for Plasmatech is set to $16. Plasmatech shares have dropped 55.81 percent over the past 52 weeks, while the S&P 500 index has surged 9.07 percent in the same period. Plasmatech shares rose 12.45 percent to $7.95 in pre-market trading.